HIV Clinical Trials in Atlanta, Georgia
15 recruitingAtlanta, Georgia
Showing 1–15 of 15 trials
Recruiting
Phase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
ViiV Healthcare150 enrolled62 locationsNCT07202546
Recruiting
Phase 1
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
HIV-1-infection
Gilead Sciences16 enrolled7 locationsNCT07055451
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 3
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)
HIV Pre-Exposure Prophylaxis
Gilead Sciences350 enrolled31 locationsNCT07047716
Recruiting
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
HIV-1-infectionPregnancy RelatedBreastfeeding
International Maternal Pediatric Adolescent AIDS Clinical Trials Group1,150 enrolled11 locationsNCT07293559
Recruiting
Phase 2
Improving Physical Ability and Cellular Senescence Elimination in HIV
FrailtyHIVAging Problems+1 more
National Institute of Allergy and Infectious Diseases (NIAID)80 enrolled27 locationsNCT07144293
Recruiting
Phase 2
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Merck Sharp & Dohme LLC84 enrolled24 locationsNCT04375800
Recruiting
Phase 1Phase 2
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)36 enrolled12 locationsNCT06071767
Recruiting
Phase 2
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)48 enrolled36 locationsNCT05719441
Recruiting
Phase 1Phase 2
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled50 locationsNCT02140255
Recruiting
Phase 1
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
HIV
National Institute of Allergy and Infectious Diseases (NIAID)42 enrolled6 locationsNCT06796686
Recruiting
Not Applicable
HIV Treatment Adherence Dose Determination Trial
HIV Infections
University of Connecticut400 enrolled2 locationsNCT04577313
Recruiting
Phase 2
Inflammation and Depression in People With HIV
DepressionAnhedoniaHIV
Emory University60 enrolled2 locationsNCT05849038
Recruiting
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
HIV InfectionsMonkeypoxAIDS
Centers for Disease Control and Prevention100 enrolled1 locationNCT06045923
Recruiting
Phase 1Phase 2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
HIV Infections
ViiV Healthcare20 enrolled8 locationsNCT05674656